Sign inJoin waitlistJoin the waitlist

Laura Jacobsen

Associate Professor, Pediatric Endocrinology University of Florida · University of Colorado School of Medicine

Credentials: · · ·

History

University of Colorado School of Medicine
Present
University of Florida College of Medicine
Present

Pediatric Endocrinology
Shands Hospital at the University of Florida - Gainesville
2015–2018
Pediatrics
University of North Carolina
2012–2015
University of Florida College of Medicine
2008–2012

Research

Type 1 diabetes mellitus
Review · Nature Reviews Disease Primers · 2017 · 1,021 citations
Introducing the Endotype Concept to Address the Challenge of Disease Heterogeneity in Type 1 Diabetes
Diabetes Care · 2020 · 289 citations
Second international consensus report on gaps and opportunities for the clinical translation of precision diabetes medicine
Review · Nature Medicine · 2023 · 184 citations

Desmond Schatz
36 papers
Michael Haller
27 papers
Emily Sims
21 papers
Jay Sosenko
19 papers
Maria Redondo
18 papers
Heba Ismail
17 papers
Brandon Nathan
11 papers
Linda DiMeglio
11 papers
Carmella Evans-Molina
10 papers · 10 as a fellow
Jay Skyler
10 papers
Kevan Herold
9 papers
Andrea Steck
7 papers

Grants

Precision Administration of Anti-Thymocyte Globulin with or Without Verapamil in Adolescents and Young Adults with Type 1 Diabetes
National Institute of Diabetes and Digestive and Kidney Diseases · R01
Contact PI · $1.5M · University of Florida
2025–2030
Diabetes Brain and Cognitive Development-Type 1 (DBCD-T1)
National Institute of Diabetes and Digestive and Kidney Diseases · U01
PI · $482.9K · University of Florida
2024–2029
Development of a Predictive Response Signature to Anti-Thymocyte Globulin in Type 1 Diabetes
National Institute of Diabetes and Digestive and Kidney Diseases · K08
Contact PI · $618.4K · University of Florida
2021–2026

Clinical trials

Precision Administration of Anti-thymocyte Globulin With or Without Verapamil
Principal investigator · Recruiting · Phase 2
University of Florida
2025–2030
PRISE (Personalized Response and Immunologic Surveillance of Endogenous C-Peptide Preservation in New, Recent, and Established Onset Type 1 Diabetes Treated With Human Anti-Thymocyte Globulin [h-ATG]) Study
Site PI · Not yet recruiting · Phase 3
University of Florida
2026–2030
A Randomized Phase 1/2 Trial of Low Dose Anti-thymocyte Globulin (ATG) With Subsequent Adalimumab or Verapamil in New Onset Type 1 Diabetes
Site PI · Recruiting · Phase 1, Phase 2
City of Hope Medical Center
2026–2031